Statements (64)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:musician
|
| gptkbp:activities |
supports vessel while healing
|
| gptkbp:approves |
treatment of coronary artery disease
|
| gptkbp:clinical_trial |
high
Phase III conducted for safety and efficacy published in peer-reviewed journals continues to evolve published in medical journals occur regularly conducted globally percutaneous coronary intervention (PCI) involves diverse populations adopted in many countries |
| gptkbp:competitors |
from other stent technologies
|
| gptkbp:complications |
thrombosis risk
assessed before procedure |
| gptkbp:delivers |
balloon-expandable
|
| gptkbp:design |
mesh structure
|
| gptkbp:diameter |
varies from 2.5 mm to 4.0 mm
|
| gptkbp:dissolved |
carbon dioxide and water
|
| gptkbp:duration |
approximately 2-3 years
depends on patient condition |
| gptkbp:education |
important for understanding treatment
|
| gptkbp:events |
show mixed results
necessary after implantation recommended at regular intervals |
| gptkbp:feedback |
generally positive
monitored post-procedure |
| gptkbp:first_introduced |
gptkb:2011
|
| gptkbp:future_plans |
focused on improving design
|
| gptkbp:healthcare |
varies by region
received in 2016 |
| https://www.w3.org/2000/01/rdf-schema#label |
Absorb bioresorbable stent
|
| gptkbp:is_compared_to |
metal stents
|
| gptkbp:is_effective_against |
varies by patient
|
| gptkbp:length |
varies from 8 mm to 38 mm
|
| gptkbp:manufacturer |
gptkb:Abbott_Laboratories
|
| gptkbp:market |
gptkb:2012
ongoing |
| gptkbp:marketed_as |
Absorb G T1 Bioresorbable Vascular Scaffold
|
| gptkbp:material |
poly-L-lactic acid (PLLA)
|
| gptkbp:mechanics |
similar to metal stents
|
| gptkbp:population |
adults
|
| gptkbp:provides_information_on |
based on individual risk factors
recommended in select patients |
| gptkbp:receives_funding_from |
various medical grants
|
| gptkbp:recruitment |
specific coronary lesions
|
| gptkbp:regulatory_compliance |
faced during approval process
CE Mark approved |
| gptkbp:replaced_by |
drug-eluting stents
|
| gptkbp:research_focus |
long-term outcomes
|
| gptkbp:safety_features |
under investigation
|
| gptkbp:side_effect |
reported in some studies
|
| gptkbp:specialties |
minimally invasive
|
| gptkbp:targets |
atherosclerosis
|
| gptkbp:training |
required for implantation
|
| gptkbp:treatment |
monitored over time
reduced restenosis rates available for coronary artery disease tracked in registries |
| gptkbp:type |
vascular scaffold
|
| gptkbp:bfsParent |
gptkb:Abbott's_vascular_business_segment
|
| gptkbp:bfsLayer |
6
|